← All stocks

MIMEDX GROUP, INC.

MDXG Net selling
CIK 0001376339 #2922 in the set updated 18 Sep 2026
Bought (120 mo)
$1.94M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$13.57M
$0.00 on a plan · $1.16M straight out of an exercise
Sold at will
$12.41M
71 of 72 sales
Net
−$11.62M
−$10.46M against sales at will

By person

38 insiders · 85 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Okumus Fund Management Ltd. entity
10% owner
$5.59M (6)
−$5.59M
21,066,710
14.45%
$156.22M
−8.6%
Taylor William Charles
President and COO
$2.04M (4) scheduled
−$2.04M
659,253
0.4523%
$4.89M
+16.4%
Capper Joseph H
Chief Executive Officer
$1.91M (3)
+$1.91M
904,656
0.6206%
$6.71M
+8,688%
Hulse William Frank IV
General Counsel and CAO
$1.53M (11)
−$1.53M
543,195
0.3727%
$4.03M
Whitlow Ricci S
Chief Operating Officer
$1.01M (5)
−$1.01M
462,825
0.3175%
$3.43M
+6,927%
Stein Robert Benjamin
President, Regenerative Med.
$907.10K (14)
−$907.10K
317,803
0.2180%
$2.36M
WRIGHT TIMOTHY R
Chief Executive Officer
$904.70K (4)
−$904.70K
1,711,324
1.17%
$12.69M
Maersk-Moller Kimberly
Chief Commercial Officer
$496.61K (4)
−$496.61K
309,630
0.2124%
$2.30M
+107.8%
KOOB CHARLES E
Director
$429.14K (1)
−$429.14K
1,431,525
0.9821%
$10.62M
+5.4%
Carlson Peter M
Chief Financial Officer
$365.34K (8)
−$365.34K
656,435
0.4504%
$4.87M
Kashyap Rohit
President, WC & Surgical
$94.55K (2)
−$94.55K
430,072
0.2951%
$3.19M
Phelan William Lawrence
Chief Accounting Officer
$92.89K (7)
−$92.89K
184,219
0.1264%
$1.37M
Turner Scott M
SVP, Operations & Procurement
$67.06K (3)
−$67.06K
226,643
0.1555%
$1.68M
+222.9%
Graves Mark
SVP & Chief Compliance Officer
$48.87K (3)
−$48.87K
133,608
0.0917%
$990.78K
+186.7%
DOUG RICE
Chief Financial Officer
$35.79K (1)
+$35.79K
399,566
0.2741%
$2.96M
+3,740%
Falcon Fund 2 Holding Company, L.P. entity
10% owner
28,195,249
19.34%
$209.08M
PETIT PARKER H
Chairman & CEO
4,647,422
3.19%
$34.46M
+7.2%
Barry Richard
Director
3,338,135
2.29%
$24.75M
+1.2%
Hack Bruce
Director
1,039,207
0.7130%
$7.71M
+46.9%
Newton Todd
Director
463,684
0.3181%
$3.44M
+1,521%
Landy Mark
EVP & Chief Strategy Officer
379,925
0.2607%
$2.82M
+246.1%
Senken Michael J.
Chief Financial Officer
273,530
0.1877%
$2.03M
+65.1%
BIERMAN JAMES L
Director
263,684
0.1809%
$1.96M
HAWKINS WILLIAM A
Director
254,931
0.1749%
$1.89M
BEHRENS M KATHLEEN
Director
212,771
0.1460%
$1.58M
BORKOWSKI EDWARD
EVP & Interim CFO
191,166
0.1312%
$1.42M
LAURENCIN CATO T
Director
181,923
0.1248%
$1.35M
BLESER JOSEPH G
Director
181,545
0.1246%
$1.35M
+52.1%
DEWBERRY J TERRY
Director
156,787
0.1076%
$1.16M
+141.3%
Haden Alexandra O
General Counsel & Secretary
154,504
0.1060%
$1.15M
+107.6%
PAPASAN LARRY W
Director
148,042
0.1016%
$1.10M
+8.9%
Giuliani Michael J
Director
130,124
0.0893%
$964.95K
YESTON NEIL
Director
126,357
0.0867%
$937.01K
+116.7%
Evans Charles Robert
Director
121,357
0.0833%
$899.93K
+127.7%
GARDNER PHYLLIS
Director
117,024
0.0803%
$867.80K
Olson Tiffany
Director
108,510
0.0744%
$804.67K
PUHY DOROTHY E
Director
108,510
0.0744%
$804.67K
Aguilar Luis A
Director
25,333
0.0174%
$187.86K
Insider
Date
Role
Action
Shares
Price
Amount
DOUG RICE
10 Mar 2026
Chief Financial Officer
Exercised, kept
243,000
$4.50
$1.09M
Hulse William Frank IV
10 Mar 2026
General Counsel and CAO
Exercised, kept
136,364
$4.50
$613.64K
Maersk-Moller Kimberly
10 Mar 2026
Chief Commercial Officer
Exercised, kept
42,845
$4.50
$192.80K
Maersk-Moller Kimberly
6 Nov 2025
Chief Commercial Officer
Sell
58,300
$7.42
$432.33K
Capper Joseph H
2 May 2025
Chief Executive Officer
Buy
200,000
$6.34
$1.27M
Maersk-Moller Kimberly
17 Mar 2025
Chief Commercial Officer
Sell
1,759
$8.04
$14.14K
Maersk-Moller Kimberly
13 Mar 2025
Chief Commercial Officer
Sell
4,106
$7.89
$32.40K
Hulse William Frank IV
13 Mar 2025
General Counsel and CAO
Sell
20,366
$7.89
$160.69K
Hulse William Frank IV
13 Mar 2025
General Counsel and CAO
Sell
34,230
$7.89
$270.07K
Hulse William Frank IV
10 Mar 2025
General Counsel and CAO
Sell
81,446
$7.80
$635.28K
Maersk-Moller Kimberly
28 Feb 2025
Chief Commercial Officer
Sell
2,111
$8.41
$17.74K
Whitlow Ricci S
13 Feb 2025
Chief Operating Officer
Sell
61,420
$8.28
$508.56K
Hulse William Frank IV
13 Mar 2024
General Counsel and CAO
Sell
20,381
$7.95
$162.03K
Whitlow Ricci S
20 Feb 2024
Chief Operating Officer
Sell
15,271
$8.01
$122.35K
Whitlow Ricci S
16 Feb 2024
Chief Operating Officer
Sell
15,493
$8.07
$125.07K
Whitlow Ricci S
15 Feb 2024
Chief Operating Officer
Sell
15,198
$8.06
$122.50K
Whitlow Ricci S
14 Feb 2024
Chief Operating Officer
Sell
15,845
$8.03
$127.27K
DOUG RICE
21 Nov 2023
Chief Financial Officer
Buy
5,000
$7.16
$35.79K
Capper Joseph H
23 Jun 2023
Chief Executive Officer
Buy
42,025
$6.50
$273.33K
Capper Joseph H
22 Jun 2023
Chief Executive Officer
Buy
57,975
$6.33
$367.10K
Stein Robert Benjamin
16 May 2023
President, Regenerative Med.
Sell
10,365
$5.95
$61.63K
Stein Robert Benjamin
15 May 2023
President, Regenerative Med.
Sell
3,607
$6.15
$22.17K
Carlson Peter M
10 May 2023
Chief Financial Officer
Sell
5,976
$5.93
$35.41K
Phelan William Lawrence
10 May 2023
Chief Accounting Officer
Sell
1,595
$5.93
$9.45K
Stein Robert Benjamin
10 May 2023
President, Regenerative Med.
Sell
5,869
$5.93
$34.78K
Hulse William Frank IV
10 May 2023
General Counsel and CAO
Sell
5,870
$5.93
$34.79K
Stein Robert Benjamin
4 May 2023
President, Regenerative Med.
Sell
51,756
$5.34
$276.47K
Phelan William Lawrence
2 May 2023
Chief Accounting Officer
Sell
5,200
$3.80
$19.74K
Carlson Peter M
25 Apr 2023
Chief Financial Officer
Sell
6,094
$3.74
$22.82K
Hulse William Frank IV
25 Apr 2023
General Counsel and CAO
Sell
5,988
$3.74
$22.42K
Stein Robert Benjamin
25 Apr 2023
President, Regenerative Med.
Sell
5,987
$3.74
$22.42K
Phelan William Lawrence
25 Apr 2023
Chief Accounting Officer
Sell
1,628
$3.74
$6.10K
Carlson Peter M
11 Apr 2023
Chief Financial Officer
Sell
6,100
$3.31
$20.19K
Hulse William Frank IV
11 Apr 2023
General Counsel and CAO
Sell
5,995
$3.31
$19.84K
Stein Robert Benjamin
11 Apr 2023
President, Regenerative Med.
Sell
5,996
$3.31
$19.85K
Phelan William Lawrence
11 Apr 2023
Chief Accounting Officer
Sell
1,632
$3.31
$5.40K
Hulse William Frank IV
7 Mar 2023
General Counsel and CAO
Sell
11,308
$4.24
$48.00K
Carlson Peter M
7 Mar 2023
Chief Financial Officer
Sell
12,056
$4.24
$51.17K
Phelan William Lawrence
7 Mar 2023
Chief Accounting Officer
Sell
3,396
$4.24
$14.41K
Stein Robert Benjamin
7 Mar 2023
President, Regenerative Med.
Sell
12,355
$4.24
$52.44K
Hulse William Frank IV
23 Feb 2023
General Counsel and CAO
Sell
15,555
$4.53
$70.48K
Carlson Peter M
23 Feb 2023
Chief Financial Officer
Sell
19,000
$4.50
$85.42K
Carlson Peter M
22 Dec 2022
Chief Financial Officer
Sell
4,992
$2.82
$14.05K
Stein Robert Benjamin
13 Sep 2022
President, Regenerative Med.
Sell
8,329
$3.46
$28.79K
Stein Robert Benjamin
12 Sep 2022
President, Regenerative Med.
Sell
19,000
$3.44
$65.28K
Stein Robert Benjamin
12 Aug 2022
President, Regenerative Med.
Sell
8,503
$4.04
$34.34K
Kashyap Rohit
9 Aug 2022
President, WC & Surgical
Sell
12,343
$4.21
$51.94K
Stein Robert Benjamin
4 Aug 2022
President, Regenerative Med.
Sell
19,500
$3.62
$70.59K
Stein Robert Benjamin
28 Jun 2022
President, Regenerative Med.
Sell
14,600
$3.47
$50.66K
WRIGHT TIMOTHY R
9 Jun 2022
Chief Executive Officer
Sell
112,000
$3.75
$420.00K
Graves Mark
9 May 2022
SVP & Chief Compliance Officer
Sell
3,891
$3.50
$13.62K
Phelan William Lawrence
6 May 2022
Chief Accounting Officer
Sell
5,750
$3.81
$21.91K
Turner Scott M
2 May 2022
SVP, Operations & Procurement
Sell
5,260
$4.00
$21.05K
Phelan William Lawrence
8 Mar 2022
Chief Accounting Officer
Sell
3,268
$4.86
$15.88K
Stein Robert Benjamin
8 Mar 2022
EVP, Research and Development
Sell
11,672
$4.86
$56.71K
Hulse William Frank IV
8 Mar 2022
General Counsel
Sell
9,990
$4.86
$48.54K
Carlson Peter M
8 Mar 2022
Chief Financial Officer
Sell
10,743
$4.86
$52.20K
Graves Mark
8 Mar 2022
SVP & Chief Compliance Officer
Sell
3,234
$4.86
$15.71K
Kashyap Rohit
8 Mar 2022
EVP & Chief Commercial Officer
Sell
8,770
$4.86
$42.61K
Turner Scott M
8 Mar 2022
SVP, Operations & Procurement
Sell
4,155
$4.86
$20.19K
WRIGHT TIMOTHY R
8 Mar 2022
Chief Executive Officer
Sell
45,611
$4.86
$221.62K
Carlson Peter M
25 Feb 2022
Chief Financial Officer
Sell
17,400
$4.83
$84.08K
Graves Mark
24 Feb 2022
SVP & Chief Compliance Officer
Sell
4,525
$4.32
$19.54K
Hulse William Frank IV
23 Feb 2022
General Counsel
Sell
13,500
$4.41
$59.54K
Turner Scott M
23 Feb 2022
SVP, Operations & Procurement
Sell
5,738
$4.50
$25.82K
WRIGHT TIMOTHY R
23 Feb 2022
Chief Executive Officer
Sell
61,000
$4.31
$263.07K
Stein Robert Benjamin
16 Aug 2021
EVP, Research and Development
Sell
9,362
$11.85
$110.97K
WRIGHT TIMOTHY R
8 Jun 2021
Chief Executive Officer
Sell
101,957
$0.00
$0.00
KOOB CHARLES E
22 Jan 2020
Director
Exercised, kept
15,000
$1.20
$18.00K
BLESER JOSEPH G
20 Jun 2019
Director
Exercised, kept
50,000
$0.70
$35.00K
DEWBERRY J TERRY
7 Jun 2019
Director
Exercised, kept
50,000
$0.70
$35.00K
Hack Bruce
7 Jun 2019
Director
Exercised, kept indirect
50,000
$0.76
$38.00K
Okumus Fund Management Ltd.
23 Jan 2019
10% owner
Sell indirect
0
$0.00
$0.00
Okumus Fund Management Ltd.
23 Jan 2019
10% owner
Sell indirect
0
$0.00
$0.00
Okumus Fund Management Ltd.
23 Jan 2019
10% owner
Sell
1,531,700
$2.78
$4.27M
Okumus Fund Management Ltd.
22 Jan 2019
10% owner
Sell indirect
0
$0.00
$0.00
Okumus Fund Management Ltd.
22 Jan 2019
10% owner
Sell indirect
0
$0.00
$0.00
Okumus Fund Management Ltd.
22 Jan 2019
10% owner
Sell
460,000
$2.88
$1.32M
Taylor William Charles
27 Feb 2018
President and COO
Exercised, kept
20,000
$1.65
$33.00K
Taylor William Charles
14 Jun 2017
President and COO
Sold after exercise
80,000
$14.52
$1.16M
Taylor William Charles
25 May 2017
President and COO
Sell
26,571
$13.74
$364.96K
Taylor William Charles
10 May 2017
President and COO
Exercised, kept
19,723
$5.07
$100.00K
Taylor William Charles
27 Apr 2017
President and COO
Sell
26,000
$11.40
$296.49K
KOOB CHARLES E
13 Mar 2017
Director
Sell
50,486
$8.50
$429.14K
Taylor William Charles
6 Mar 2017
President and COO
Sell
26,000
$8.18
$212.79K

What was left out

Form 4 filings counted 258
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 71
Transactions with no price 0
Shares from compensation/vesting 42,227,945
Sales filed before the plan box existed 42
History held since 8 Sep 2016